• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多次速率输注后犬体内甲氨蝶呤的清除率研究。

Clearance studies of methotrexate in dogs after multiple-rate infusion.

作者信息

Lui C Y, Lee M G, Chiou W L

出版信息

Cancer Res. 1985 Apr;45(4):1545-8.

PMID:3978622
Abstract

Plasma, renal, and nonrenal clearances of methotrexate as well as their interrelationship were studied in five conditioned male beagle-mongrel dogs using the multiple-rate infusion method. Steady-state plasma methotrexate concentrations of 1, 20, and 100 micrograms/ml were targeted for by i.v. bolus doses followed by i.v. infusions. An isotonic solution of sodium bicarbonate or ammonium chloride was simultaneously infused to study the effect of acid-base imbalance on the clearances. NaCl solution (0.9%) infusion served as a control. Plasma and urine concentrations of methotrexate were quantitated by a sensitive high-performance liquid chromatographic method. Distortion of body acid-base balance did not significantly change the clearances of methotrexate. The results showed that the plasma clearance (4.02 to 4.68 ml/min/kg) of methotrexate was relatively constant over the concentration range studied. The renal and nonrenal clearances, on the other hand, were concentration dependent. As the plasma methotrexate concentration increased from 1 to 20 or 100 micrograms/ml, renal clearance decreased from 3.60 to 4.28 ml/min/kg to 2.62 to 2.73 ml/min/kg, and nonrenal clearance increased form 0.35 to 0.42 ml/min/kg to 1.38 to 1.74 ml/min/kg. Concentration-dependent renal clearance may be due to saturation of the process involving active tubular secretion of methotrexate.

摘要

采用多速率输注法,在5只雄性条件性比格杂种犬中研究了甲氨蝶呤的血浆清除率、肾清除率和非肾清除率及其相互关系。通过静脉推注剂量,随后进行静脉输注,将稳态血浆甲氨蝶呤浓度目标设定为1、20和100微克/毫升。同时输注碳酸氢钠或氯化铵等渗溶液,以研究酸碱失衡对清除率的影响。输注0.9%氯化钠溶液作为对照。采用灵敏的高效液相色谱法对甲氨蝶呤的血浆和尿液浓度进行定量。机体酸碱平衡的改变并未显著改变甲氨蝶呤的清除率。结果表明,在所研究的浓度范围内,甲氨蝶呤的血浆清除率(4.02至4.68毫升/分钟/千克)相对恒定。另一方面,肾清除率和非肾清除率与浓度有关。随着血浆甲氨蝶呤浓度从1微克/毫升增加到20或100微克/毫升,肾清除率从3.60至4.28毫升/分钟/千克降至2.62至2.73毫升/分钟/千克,非肾清除率从0.35至0.42毫升/分钟/千克增至1.38至1.74毫升/分钟/千克。浓度依赖性肾清除率可能是由于甲氨蝶呤主动肾小管分泌过程的饱和所致。

相似文献

1
Clearance studies of methotrexate in dogs after multiple-rate infusion.多次速率输注后犬体内甲氨蝶呤的清除率研究。
Cancer Res. 1985 Apr;45(4):1545-8.
2
Urinary pH and urine flow independent renal clearance of methotrexate in dogs.犬尿液pH值和尿流量对甲氨蝶呤肾脏清除率的影响(独立因素)
J Pharmacokinet Biopharm. 1985 Apr;13(2):159-71. doi: 10.1007/BF01059396.
3
Concentration and pH dependent steady-state volume of distribution of methotrexate estimated by a simple physiologically based method.
J Pharmacokinet Biopharm. 1984 Dec;12(6):597-610. doi: 10.1007/BF01059555.
4
Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.多次剂量输注后兔体内甲氨蝶呤和7-羟基甲氨蝶呤的清除率研究。
J Pharmacokinet Biopharm. 1983 Oct;11(5):515-27. doi: 10.1007/BF01062209.
5
A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
Int J Clin Pharmacol Ther Toxicol. 1984 Jan;22(1):1-6.
6
Renal clearance of substituted hippurates in the dog. II. 4-Amino-, hydroxy- and methoxy-substituted benzoylglycines.犬体内取代马尿酸盐的肾清除率。II. 4-氨基、羟基和甲氧基取代的苯甲酰甘氨酸。
J Pharmacol Exp Ther. 1989 Jan;248(1):436-46.
7
The renal actions of adenosine.腺苷的肾脏作用。
Acta Physiol Hung. 1994;82(3):215-28.
8
Amiodarone modulates pharmacokinetics of low-dose methotrexate in rats.
Biopharm Drug Dispos. 2008 Jul;29(5):289-99. doi: 10.1002/bdd.614.
9
The renal clearance of digoxin is dependent upon the serum digoxin concentration.地高辛的肾脏清除率取决于血清地高辛浓度。
J Pharmacol Exp Ther. 1980 Dec;215(3):681-4.
10
Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.泼尼松和泼尼松龙在兔体内稳态时的药代动力学
Drug Metab Dispos. 1985 Jul-Aug;13(4):503-9.

引用本文的文献

1
Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.人体和临床前动物模型中未变化药物的尿排泄检查:提高人类代谢不良的预测性。
Pharm Res. 2021 Jul;38(7):1139-1156. doi: 10.1007/s11095-021-03076-y. Epub 2021 Jul 12.